Evidence map›Paper›PMID 30452547›Full record

ArticleBioinformatics (Oxford, England)2019

DiPhiSeq: robust comparison of expression levels on RNA-Seq data with large sample sizes.

Jun Li, Alicia T Lamere

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jun LiDepartment of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, IN, USA.
Alicia T LamereMathematics Department, Bryant University, Smithfield, RI, USA.

Funding

Statistical analysis of single cell RNA-sequencing data: detecting dropouts and removing the cell-cycle effectR03CA212964 · NCI · UNIVERSITY OF NOTRE DAME · PI LI, JUN · 2017 to 2018
$155k
NCI NIH HHS R03 CA212964
6 · The paper itself

Abstract

motivationIn the analysis of RNA-Seq data, detecting differentially expressed (DE) genes has been a hot research area in recent years and many methods have been proposed. DE genes show different average expression levels in different sample groups, and thus can be important biological markers. While generally very successful, these methods need to be further tailored and improved for cancerous data, which often features quite diverse expression in the samples from the cancer group, and this diversity is much larger than that in the control group.

resultsWe propose a statistical method that can detect not only genes that show different average expressions, but also genes that show different diversities of expressions in different groups. These 'differentially dispersed' genes can be important clinical markers. Our method uses a redescending penalty on the quasi-likelihood function, and thus has superior robustness against outliers and other noise. Simulations and real data analysis demonstrate that DiPhiSeq outperforms existing methods in the presence of outliers, and identifies unique sets of genes. AVAILABILITY AND IMPLEMENTATION: DiPhiSeq is publicly available as an R package on CRAN: https://cran.r-project.org/package=DiPhiSeq. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

RNA-SeqExome SequencingLikelihood FunctionsSample SizeSequence Analysis, RNASoftware

Identifiers

PMID30452547
PMCPMC6596898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.